Conatus Pharmaceuticals (CNAT) Tops Q3 EPS by 3c

November 8, 2016 4:25 PM EST
Get Alerts CNAT Hot Sheet
Trade CNAT Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Conatus Pharmaceuticals (NASDAQ: CNAT) reported Q3 EPS of ($0.31), $0.03 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Conatus Pharmaceuticals (CNAT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment